3D-Printed Medical Implant Markets explore the revenue potential for 3D printed medical implant markets. Printed implants of standard sizing in hip markets are approaching significant volumes, with more implant types are now beginning to reach critical minimum real world trial length to be determined medically successful.

The global 3D printing medical implants market is estimated to grow at a higher rate up to 2020. Continuous technological advancements in healthcare, 3D printing, government and private funding will support the development of novel products/technologies. The increasing application of 3D printing in the healthcare industry will be the key factor fueling the growth of the 3D printing medical implants market. Furthermore, rising demand for organ transplantation, expiry of key patents, and strong mergers and acquisitions to enhance market share are offering high-growth opportunities for the market players. However, the stringent regulatory process for the approval of 3D-printed medical implants and high cost of 3D-printed organs and tissues are some of the key restraints hampering market growth.

China, India, Brazil, and South Korea are considered as emerging markets which offer high-growth potential for companies engaged in the development and distribution of 3D printing solutions. Increasing education and awareness about 3D printing technology, establishment of new 3D printing research and training centers, and government funding to support the application of 3D printing in the healthcare industry are key factors propelling the growth of 3D printing in emerging markets. Leading market players will be Stratasys Ltd. (Israel & U.S.), EnvisionTEC GmbH (Germany), and Materialise NV (Belgium) and these companies have collaborated with local suppliers to expand their distribution network in these emerging nations.

As of 2014 Stratasys Ltd. (Israel & U.S.) held the leadership position in the global 3D printing medical implants market. Over the past three years, the company adopted new product launches; distribution agreements, partnerships, and collaborations; and acquisitions as its key growth strategies to ensure its dominance in the market. In addition, 3D Systems Corporation (U.S.), EnvisionTEC GmbH (Germany), EOS GmbH Electro Optical Systems (Germany), Renishaw plc (U.K.), Materialise NV (Belgium), 3T RPD, Ltd. (U.K.), Arcam AB (Sweden), Concept Laser GmbH (Germany), and Prodways (France) are the other key players in this market.

These early trials have paved the way for more common orthopedic and medical implant procedures to achieve widespread commercial success in the future, with applications expanding rapidly into knee, spinal, shoulder, and other implants to serve specialty cases where traditional treatments would fail.